In response to the incident of damage to consumer health caused by Japan's Kobayashi Pharmaceutical Co., Ltd. health products containing red yeast ingredients, the Japanese Nephrology Society published an analysis report on June 30, which surveyed some consumers with impaired health. Among them, 105 patients with impaired renal function due to taking this supplement still did not recover their kidney function after treatment. Japan's Kobayashi Pharmaceutical Co., Ltd. said on July 1 that it has submitted an investigation plan to the Ministry of Health, Labor, and Welfare in response to health problems caused by the company's health products containing red yeast. The plan involves 76 newly discovered cases of suspected deaths due to taking related health products. The details of the investigation plan have not been disclosed.

Zhitongcaijing · 07/01 10:17
In response to the incident of damage to consumer health caused by Japan's Kobayashi Pharmaceutical Co., Ltd. health products containing red yeast ingredients, the Japanese Nephrology Society published an analysis report on June 30, which surveyed some consumers with impaired health. Among them, 105 patients with impaired renal function due to taking this supplement still did not recover their kidney function after treatment. Japan's Kobayashi Pharmaceutical Co., Ltd. said on July 1 that it has submitted an investigation plan to the Ministry of Health, Labor, and Welfare in response to health problems caused by the company's health products containing red yeast. The plan involves 76 newly discovered cases of suspected deaths due to taking related health products. The details of the investigation plan have not been disclosed.